Assoc. Prof. NAZLI ERDOĞDU

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Oral docetaxel delivery with cationic polymeric core-shell nanocapsules: In vitro and in vivo evaluation

Daşkın D., Erdoğar N., İSKİT A. B., BİLENSOY E.

Journal of Drug Delivery Science and Technology , vol.80, 2023 (SCI-Expanded)

Q-tof lc/ms-based untargeted metabolomics approach to evaluate the effect of folate-conjugated cyclodextrins on triple-negative breast cancer cells

Varol I., KAPLAN O., Erdoğar N., Öncül S., Nielsen T. T., ERCAN A., et al.

Current Pharmaceutical Analysis , vol.17, no.10, pp.1272-1281, 2021 (SCI-Expanded) Sustainable Development

Development of oral aprepitant-loaded chitosan-polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation

Erdogar N., Akkin S., Nielsen T. T., Ozcelebi E., Erdogdu B., NEMUTLU E., et al.

JOURNAL OF PHARMACEUTICAL INVESTIGATION , vol.51, no.3, pp.297-310, 2021 (SCI-Expanded)

Determination and validation of aprepitant in rat plasma using LC-MS/MS.

Erdogar N., REÇBER T., B Iskit A. B., BİLENSOY E., KIR S., NEMUTLU E.

Bioanalysis , vol.13, no.5, pp.363-372, 2021 (SCI-Expanded)

Erlotinib complexation with randomly methylated beta-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer

Erdogar N., Akkin S., VARAN G., BİLENSOY E.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , vol.26, pp.797-806, 2021 (SCI-Expanded) Sustainable Development

Improved oral bioavailability of anticancer drug tamoxifen through complexation with water soluble cyclodextrins: in vitro and in vivo evaluation

Erdoğar N., NEMUTLU E., İSKİT A. B., KARA Ş. A., Teksin Z. Ş., BİLENSOY E.

JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.96, no.1-2, pp.81-91, 2020 (SCI-Expanded)

Articles Published in Other Journals

Combination of daratumumab and doxorubicin loaded polycaprolactone nanoparticles in the treatment of diffuse large B-cell lymphoma

Erdoğdu N.

Annals of Medical Research , vol.29, no.3, pp.198-202, 2022 (Peer-Reviewed Journal)

Development of oral tablet formulation containing erlotinib: Randomly methylated-β-cyclodextrin inclusion complex using direct compression method Doğrudan basım yöntemi kullanılarak randomize metillenmiş-β-siklodekstrin inklüzyon kompleksi içeren erlotinib oral tablet formülasyonu geliştirilmesi

Erdoğar N.

Turkish Journal of Pharmaceutical Sciences , vol.18, no.5, pp.589-596, 2021 (ESCI)

Nanocapsules for drug delivery: An updated review of the last decade

Erdoğar N., Akkin S., BİLENSOY E.

Recent Patents on Drug Delivery and Formulation , vol.12, no.4, pp.252-266, 2018 (Scopus)

Refereed Congress / Symposium Publications in Proceedings

Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer

ERDOĞDU N., Akkın S., VARAN G., BİLENSOY E.

13th Internation symposium of Pharmaceutical Science, Ankara, Turkey, 22 - 25 June 2021

Farelerde Tamoksifen ve Majör Metaboliti N-Desmetil-Tamoksifen’in LC- MS/MS Yöntemiyle Tayini

ERDOĞAR N., NEMUTLU E., KIR S., İSKİT A. B., BİLENSOY E.

XVI. Ulusal Spektroskopi Kongresi, Turkey, 7 - 09 November 2019

Novel Folate-Conjugated Amphiphilic Cyclodextrin Nanoparticles For Paclitaxel Delivery in Recurrent Metastatic Breast Cancer

ERDOĞAR N., ESENDAĞLI G., NIELSEN T. T., ESENDAĞLI YILMAZ G., SARGON M. F., ÖNER L., et al.

Innovation in Medicine Summit-3, 11 - 13 May 2017 Sustainable Development

In Vitro and In Vivo Evaluation of Tumor Targeted Nanoparticles for Paclitaxel Delivery with Folate conjugated Amphiphilic Cyclodextrin Derivatives

ERDOĞAR N., TERNDRUP N., ÖNER L., ESENDAĞLI G., BİLENSOY E.

4th European Conference on Cyclodextrins (EUROCD 2015), 6 - 09 October 2015

Optimization by 32 Factorial Design of Tumor Targeted Nanoparticles for Paclitaxel Delivery with Folate conjugated Amphiphilic Cyclodextrin

ERDOĞAR N., ÖNER L., ESENDAĞLI G., NİELSEN T., BİLENSOY E.

EUFEPS Annual Meeting, 15 - 17 June 2015

Comparative Evaluation of In Vitro Parameters of Tamoxifen Citrate Loaded Chitosan, Poly(ε-Caprolactone) and Poly(Lactide-co-Glycolide) Nanoparticles

Launay M., Gegu C., Leturgez T., Çırpanlı Y., Öztürk Atar K., Erdoğdu N., et al.

7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Valletta, Malta, 8 - 11 March 2010

Books & Book Chapters

Folate receptor-mediated targeted breast cancer nanomedicine

Varan G., Varan C., Erdoğdu N., Bilensoy E.

in: Targeted Nanomedicine for Breast Cancer Therapy, Shivani Rai Paliwal,Rishi Paliwal, Editor, Academic Press , London, pp.153-169, 2022 Sustainable Development

Biodistribution of polymeric, polysaccharide and metallic nanoparticles

Erdoğdu N., Varan G., Varan C., Bilensoy E.

in: Characterization of Pharmaceutical Nano- and Microsystems, Peltonen Leena,Douroumis Dennis,Fahr Alfred,Siepmann Jurgen,Snowden Martin J., Editor, John Wiley & Sons, West Sussex, UK , Cambridge, pp.275-290, 2020

Cyclodextrin Based Nano-Systems: Current Status and Future Prospects

VARAN C., VARAN G., ERDOĞAR N., BİLENSOY E.

in: Drug Delivery Nanosystems: From Bioinspiration and Biomimetics to Clinical Applications, Pippa Natassa, Demetzos Costas, Pispas Stergios, Editor, Pan Stanford, pp.29-49, 2019

Cyclodextrin-based polymeric nanosystems

ERDOĞAR N., VARAN G., VARAN C., BİLENSOY E.

in: Drug Targeting and Stimuli Sensitive Drug Delivery Systems, Alina M. Holban, Editor, William Andrew, pp.715-748, 2018

Cyclodextrin-Based Nanosystems in Targeted Cancer Therapy

ERDOĞAR N., BİLENSOY E.

in: Cyclodextrin Applications in Medicine, Food, Environment and Liquid Crystals, Gregorio Crini, Eric Lichtfouse, Sophie Fourmentin, Editor, Springer, Cham, pp.59-80, 2018

Metrics

Publication

Citation (WoS)

246

H-Index (WoS)

Citation (Scopus)

314

H-Index (Scopus)

Project

Open Access

UN Sustainable Development Goals

Publications & Works